PolyPid (PYPD)

PolyPid (PYPD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $103M; returns 1 day +2.3%, 1 week +11.2%, 1 year +52.6%.

PolyPid Ltd. is a late-stage biopharmaceutical company focused on improving surgical outcomes through its proprietary PLEX (Polymer-Lipid Encapsulation matrix) technology. This technology enables targeted, localized, and prolonged release of therapeutics. PolyPid is currently pre-revenue and is working towards commercial readiness.

Groups PYPD belongs to

• Biopharmaceutical
• Israel Companies
• Biotechnology
• Healthcare
• Clinical Stage Biotech
• Pharmaceuticals
• Israel
• Life Sciences
• Minimally Invasive Surgery
• Fast Track Designation
• Clinical Stage

PYPD financial model: income statement, cash flow and balance sheet